<DOC>
	<DOCNO>NCT02454569</DOCNO>
	<brief_summary>The VFHCS long-term prospective cohort study HIV infect patient resource-poor rural setting India . The aim study use data collect routine clinical care order describe epidemiology HIV related condition investigator area , study effectiveness health intervention `` real-world '' setting ( implementation operational research ) .</brief_summary>
	<brief_title>Vicente Ferrer HIV Cohort Study</brief_title>
	<detailed_description>Andhra Pradesh state high burden HIV India . Anantapur district situate South border Andhra Pradesh 72 % rural population adult literacy rate 74.1 % men 54.3 % woman . In Anantapur , HIV epidemic largely driven heterosexual transmission characterize poor socioeconomic condition high level illiteracy . Rural Development Trust ( RDT ) nongovernmental organization , provide medical care people live HIV free charge , include medicine , consultation admission charge . In Bathalapalli Hospital , outpatient clinic 71 bed allocate exclusively HIV tuberculosis infect patient . The Vicente Ferrer HIV Cohort Study ( VFHCS ) prospective open cohort study HIV infect patient attend Bathalapalli RDT Hospital . Routine clinical data patient collect prospectively since September 2009 enter SQL-server database use C # front end . Details route transmission , HIV associate risk factor socio-demographic data collect enrolment . Data collect include medical treatment ( antiretroviral treatment medication ) , laboratory investigation ( haemogram , renal function test , liver function test , CD4 lymphocyte count , bacterial infection ) , standardized diagnosis . The objective VFHCS describe social medical aspect relate HIV investigator set , include : 1 . Epidemiology : trend HIV incidence , transmission mechanism , socioeconomic risk factor associate HIV . 2 . Incidence prevalence opportunistic infection , especially tuberculosis cryptococcosis . 3 . Life expectancy factor associate mortality 4 . Describe retention across continuum care investigate factor associate loss follow-up . 5 . Toxicity effectiveness antiretroviral therapy . 6 . Effectiveness programmes prevent mother child transmission . 7 . Incidence prevalence non-communicable disease cancer cardiovascular disease .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Opportunistic Infections</mesh_term>
	<mesh_term>Cryptococcosis</mesh_term>
	<criteria>Positive serology HIV Refuse consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>